Skeletal Muscle Degenerative Diseases and Strategies for Therapeutic Muscle Repair

Muscle necrosis caused by snake venoms and toxins

Harris, J. B., & Cullen, M. J. (1990) · Electron Microscopy Reviews · doi:10.1016/0892-0354(90)90001-9 · Cited by 123

Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle

Huang, Y., de Morrée, A., van Remoortere, A., Bushby, K. M. D., Frants, R. R., den Dunnen, J. T., & van der Maarel, S. M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn081 · Cited by 122

Isolation of myotoxic component from rattlesnake (Crotalus viridis viridis) venom. Electron microscopic analysis of muscle damage.

Ownby, C. L., Cameron, D., & Tu, A. T. (1976) · PubMed · Cited by 121

Functional Myogenic Engraftment from Mouse iPS Cells

Darabi, R., Pan, W., Bosnakovski, D., Baik, J., Kyba, M., & Perlingeiro, R. C. R. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9258-2 · Cited by 121

The Neurotoxicity of the Venom Phospholipases A2, Notexin and Taipoxin

Harris, J. B., Grubb, B. D., Maltin, C. A., & Dixon, R. W. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7275 · Cited by 121

Improved Contractile Function of the mdx Dystrophic Mouse Diaphragm Muscle after Insulin-Like Growth Factor-I Administration

Gregorevic, P., Plant, D. R., Leeding, K. S., Bach, L. A., & Lynch, G. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64502-6 · Cited by 120

Melittin and phospholipase A2 from bee (Apis mellifera) venom cause necrosis of murine skeletal muscle in vivo

Ownby, C. L., Powell, J. R., Jiang, M.-S., & Fletcher, J. E. (1997) · Toxicon · doi:10.1016/s0041-0101(96)00078-5 · Cited by 119

Complement in Ischemia Reperfusion Injury

Riedemann, N. C., & Ward, P. A. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63830-8 · Cited by 118

Stem cells for skeletal muscle repair

Shadrach, J., & Wagers, A. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0027 · Cited by 113

Absence of Dysferlin Alters Myogenin Expression and Delays Human Muscle Differentiation “in Vitro”

de Luna, N., Gallardo, E., Soriano‐Navarro, M., Domínguez‐Perles, R., de la Torre, C., Rojas‐García, R., García‐Verdugo, J. M., & Illa, I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601885200 · Cited by 112

Inflammatory muscle diseases: a critical review on pathogenesis and therapies

Dalakas, M. C. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.03.001 · Cited by 111

Muscle stem cells

Goldring, K., Partridge, T. A., & Watt, D. J. (2002) · The Journal of Pathology · doi:10.1002/path.1157 · Cited by 105

Loss of selenoprotein N function causes disruption of muscle architecture in the zebrafish embryo

Deniziak, M., Thisse, C., Rederstorff, M., Hindelang, C., Thisse, B., & Lescure, A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.005 · Cited by 104

IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice

Lynch, G. S., Cuffe, S. A., Plant, D. R., & Gregorevic, P. (2001) · Neuromuscular Disorders · doi:10.1016/s0960-8966(00)00192-9 · Cited by 102

Dynamic distribution of muscle-specific calpain in mice has a key role in physical-stress adaptation and is impaired in muscular dystrophy

Ojima, K., Kawabata, Y., Nakao, H., Nakao, K., Doi, N., Kitamura, F., Ono, Y., Hata, S., Suzuki, H., Kawahara, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40658 · Cited by 102

Calpain 3 cleaves filamin C and regulates its ability to interact with γ‐ and δ‐sarcoglycans

Guyon, J. R., Kudryashova, E., Potts, A., Dalkilic, I., Brosius, M. A., Thompson, T. G., Beckmann, J. S., Kunkel, L. M., & Spencer, M. J. (2003) · Muscle & Nerve · doi:10.1002/mus.10465 · Cited by 102

Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice

Casar, J. C., McKechnie, B. A., Fallon, J. R., Young, M. F., & Brandan, E. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2003.12.025 · Cited by 101

Myotonic dystrophy: present management, future therapy

(2004) · doi:10.1093/oso/9780198527824.001.0001 · Cited by 97

Determinants of Skeletal Muscle Contributions from Circulating Cells, Bone Marrow Cells, and Hematopoietic Stem Cells

Sherwood, R. I., Christensen, J. L., Weissman, I. L., & Wagers, A. J. (2004) · Stem Cells · doi:10.1634/stemcells.2004-0090 · Cited by 97

Structural Basis of Membrane-induced Cardiotoxin A3 Oligomerization

Forouhar, F., Huang, W., Liu, J., Chien, K., Wu, W., & Hsiao, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208650200 · Cited by 96

Move over ZFNs

(2011) · Nature Biotechnology · doi:10.1038/nbt.1935 · Cited by 95

Functional Substitution by TAT-Utrophin in Dystrophin-Deficient Mice

Sonnemann, K. J., Heun‐Johnson, H., Turner, A., Baltgalvis, K. A., Lowe, D. A., & Ervasti, J. M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000083 · Cited by 93

Nerve, muscle, and neuromuscular junction electrophysiology at high temperature

Rutkove, S. B., Kothari, M. J., & Shefner, J. M. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199704)20:4 · Cited by 93

The Dynamic Z Bands of Striated Muscle Cells

Sanger, J. M., & Sanger, J. W. (2008) · Science Signaling · doi:10.1126/scisignal.132pe37 · Cited by 89

Similarities and differences in mechanisms of cardiotoxins, melittin and other myotoxins

Fletcher, J. E., Hubert, M. D., Wieland, S. J., Gong, Q.-H., & Jiang, M.-S. (1996) · Toxicon · doi:10.1016/s0041-0101(96)00105-5 · Cited by 88

Limb girdle muscular dystrophies

Nigro, V., Aurino, S., & Piluso, G. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834aa38d · Cited by 85

Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3

Hernández-Deviez, D. J., Martin, S., Laval, S. H., Lo, H. P., Cooper, S. T., North, K. N., Bushby, K. M. D., & Parton, R. G. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi434 · Cited by 82

Lack of Correlation between Outcomes of Membrane Repair Assay and Correction of Dystrophic Changes in Experimental Therapeutic Strategy in Dysferlinopathy

Lostal, W., Bartoli, M., Roudaut, C., Bourg, N., Krahn, M., Pryadkina, M., Borel, P., Suel, L., Roche, J. A., Stockholm, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038036 · Cited by 79

Changes in motor end-plates resulting from muscle fibre necrosis and regeneration

Duchen, L. W., Excell, B. J., Patel, R., & Smith, B. (1974) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(74)90041-0 · Cited by 76

Muscle engraftment of myogenic progenitor cells following intraarterial transplantation

Bachrach, E., Pérez, A. L., Choi, Y., Illigens, B. M. W., Jun, S. J., del Nido, P. J., McGowan, F. X. J., Li, S., Flint, A., Chamberlain, J. S., et al. (2006) · Muscle & Nerve · doi:10.1002/mus.20560 · Cited by 76

Emerging strategies for cell and gene therapy of the muscular dystrophies

Muir, L. A., & Chamberlain, J. S. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001100 · Cited by 75

Mitsugumin 53 (MG53) facilitates vesicle trafficking in striated muscle to contribute to cell membrane repair

Weisleder, N., Takeshima, H., & Ma, J. (2009) · Communicative & Integrative Biology · doi:10.4161/cib.2.3.8077 · Cited by 74

The 2014 version of the gene table of monogenic neuromuscular disorders (nuclear genome)

Kaplan, J., & Hamroun, D. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.10.006 · Cited by 73

Biglycan Is an Extracellular MuSK Binding Protein Important for Synapse Stability

Amenta, A. R., Creely, H., Mercado, M. L. T., Hagiwara, H., McKechnie, B. A., Lechner, B. E., Rossi, S. G., Wang, Q., Owens, R. T., Marrero, E., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4610-11.2012 · Cited by 73

Emery-Dreifuss muscular dystrophy

Muchir, A., & Worman, H. J. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0025-3 · Cited by 70

Clinical Characteristics of Aged Becker Muscular Dystrophy Patients with Onset after 30 Years

Yazaki, M., Yoshida, K., Nakamura, A., Koyama, J., Nanba, T., Ohori, N., & Ikeda, S.-I. (1999) · European Neurology · doi:10.1159/000008089 · Cited by 69

Congenital Muscular Dystrophies Involving the O-Mannose Pathway

Martin, P. T. (2007) · Current Molecular Medicine · doi:10.2174/156652407780831601 · Cited by 69

Insulin-like Growth Factor-I in Muscle Metabolism and Myotherapies

Singleton, J. R., & Feldman, E. L. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0416 · Cited by 67

Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display

Huang, Y., Verheesen, P., Roussis, A., Frankhuizen, W. S., Ginjaar, I. B., Haldane, F., Laval, S., Anderson, L. V. B., Verrips, T. C., Frants, R. R., et al. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201414 · Cited by 67

Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IκBα/NF-κB survival pathway in skeletal muscle

Baghdiguian, S., Richard, I., Martin, M., Coopman, P. J. P., Beckmann, J. S., Mangeat, P. H., & Lefranc, G. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100225 · Cited by 64

Some observations on variations in filament overlap in tetanized muscle fibres and fibres stretched during a tetanus, detected in the electron microscope after rapid fixation

Brown, L. M., & Hill, L. (1991) · Journal of Muscle Research and Cell Motility · doi:10.1007/bf01774036 · Cited by 62

Laminin-111: A Potential Therapeutic Agent for Duchenne Muscular Dystrophy

Goudenege, S., Lamarre, Y., Dumont, N. A., Rousseau, J., Frenette, J., Skuk, D., & Tremblay, J. P. (2010) · Molecular Therapy · doi:10.1038/mt.2010.165 · Cited by 61

Muscular dystrophies due to defective glycosylation of dystroglycan.

Francesco Muntoni, A., Brockington, M., Godfrey, C., Ackroyd, M. R., Robb, S. A., Manzur, A. Y., Kinali, M., Mercuri, E. M., Kaluarachchi, M. R., Feng, L., et al. (2007) · Europe PMC (PubMed Central) · Cited by 58

Resealing of transected myelinated mammalian axons in vivo: evidence for involvement of calpain

Howard, M. J., David, G., & Barrett, J. N. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00195-5 · Cited by 58

Administration of insulin‐like growth factor‐I improves fatigue resistance of skeletal muscles from dystrophic mdx mice

Gregorevic, P., Plant, D. R., & Lynch, G. S. (2004) · Muscle & Nerve · doi:10.1002/mus.20082 · Cited by 58

Morphological changes induced by crotoxin in murine nerve and neuromuscular junction

Gopalakrishnakone, P., & Hawgood, B. J. (1984) · Toxicon · doi:10.1016/0041-0101(84)90162-4 · Cited by 58

Impending therapies for Duchenne muscular dystrophy

Partridge, T. A. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834aa3f1 · Cited by 54

Congenital Muscular Dystrophies: Toward Molecular Therapeutic Interventions

Collins, J. J., & Bönnemann, C. G. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0092-8 · Cited by 52

Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy

Darabi, R., Baik, J., Clee, M., Kyba, M., Tupler, R. G., & Perlingeiro, R. C. R. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.002 · Cited by 48

Cell Cycle Regulation During Proliferation and Differentiation of Mammalian Muscle Precursor Cells

Ciemerych, M. A., Archacka, K., Grabowska, I., & Gawor, M. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-19065-0_20 · Cited by 47

Telethonin-deficiency initially presenting as a congenital muscular dystrophy

Ferreiro, A., Mezmezian, M. B., Olivé, M., Herlicoviez, D., Fardeau, M., Richard, P., & Romero, N. B. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.03.005 · Cited by 47

A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24

Ber, I. L. (2004) · Brain · doi:10.1093/brain/awh216 · Cited by 47

Limb-girdle muscular dystrophy

Mathews, K. D., & Moore, S. A. (2003) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-003-0042-9 · Cited by 45

Satellite cell activation after muscle damage in young and adult rats

Jacobs, S. C. J. M., Wokke, J. H. J., Bär, P. R., & Bootsma, A. L. (1995) · The Anatomical Record · doi:10.1002/ar.1092420306 · Cited by 39

Immunological hurdles in the path to gene therapy for Duchenne muscular dystrophy

Wells, D. J., Ferrer, A., & Wells, K. E. (2002) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940200515x · Cited by 38

Higher content of insulin-like growth factor-I in dystrophic mdx mouse: potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function

Luca, A. D., Pierno, S., Camerino, C., Cocchi, D., & Camerino, D. C. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(98)00092-3 · Cited by 32

Point mutation and polymorphism in Duchenne/Becker Muscular Dystrophy (D/BMD) patients

Chaturvedi, L. S., Mukherjee, M., Srivastava, S., Mittal, R. D., & Mittal, B. (2001) · Experimental & Molecular Medicine · doi:10.1038/emm.2001.41 · Cited by 24

TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice

Call, J. A., Ervasti, J. M., & Lowe, D. A. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00248.2011 · Cited by 22

Caveolin 3 Is Associated with the Calcium Release Complex and Is Modified via in Vivo Triadin Modification

Vassilopoulos, S., Oddoux, S., Groh, S., Cacheux, M., Fauré, J., Brocard, J., Campbell, K. P., & Marty, I. (2010) · Biochemistry · doi:10.1021/bi100796v · Cited by 19

Pharmacologic and genetic therapy for childhood muscular dystrophies

Escolar, D. M., & Scacheri, C. (2001) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-001-0013-y · Cited by 17

Induced pluripotent stem cells – alchemist's tale or clinical reality?

Rashid, S. T., & Vallier, L. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001596 · Cited by 17

How do mutations in lamins A and C cause disease?

Worman, H. J., & Courvalin, J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420832 · Cited by 14

T.O.4 A phase I/IIa study on antisense compound PRO051 in patients with Duchenne muscular dystrophy

Goemans, N., Buyse, G., Tulinius, M., Verschuuren, J. J. G. M., de Kimpe, S. J., & van Deutekom, J. C. T. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.06.359 · Cited by 10

Gene table of monogenic neuromuscular disorder (nuclear genome only)

(2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.12.001 · Cited by 6

Stem Cell Regulators

(2011) · Vitamins and hormones · doi:10.1016/c2010-0-66767-8 · Cited by 3

Preface

Litwack, G. (2011) · Vitamins and hormones · doi:10.1016/b978-0-12-386015-6.00046-9 · Cited by 1

Untitled work

(2000) · doi:10.1002/1531-8249(200012)48:6

A Special Population of Regulatory T Cells Potentiates Muscle Repair

Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J. L., Cerletti, M., Jang, Y., Sefik, E., Tan, T. G., Wagers, A. J., Benoist, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.054 · Cited by 1,234

NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice

Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255

In vivo gene editing in dystrophic mouse muscle and muscle stem cells

Tabebordbar, M., Zhu, K., Cheng, J. K. W., Chew, W. L., Widrick, J. J., Yan, W. X., Maesner, C., Wu, E. Y., Xiao, R., Ran, F. A., et al. (2016) · Science · doi:10.1126/science.aad5177 · Cited by 1,046

Stem cell aging: mechanisms, regulators and therapeutic opportunities

Oh, J., Lee, Y. D., & Wagers, A. J. (2014) · Nature Medicine · doi:10.1038/nm.3651 · Cited by 796

Tissue Tregs

Panduro, M., Benoist, C., & Mathis, D. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095948 · Cited by 536

Mechanisms of Muscle Degeneration, Regeneration, and Repair in the Muscular Dystrophies

Wallace, G. Q., & McNally, E. M. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163216 · Cited by 343

Stem Cells in Skeletal Muscle

Polesskaya, A., & Rudnicki, M. A. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-732-1_3

Regenerative Therapy

Morgan, J. E., Brimah, K., & Collins, C. A. (2006) · CRC Press eBooks · doi:10.3109/9780849374456-16

Downstream Pathways of Dystrophin Deficiency in Duchenne Muscular Dystrophy: Implications for Muscle Degeneration and Regeneration

Epis, R., Rovetta, G., Ferrari, G., Bonfanti, C., Careccia, G., & Messina, G. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70333 · Cited by 1

Attenuating Muscle Wasting: Cell and Gene Therapy Approaches

Musarò, A., & Rosenthal, N. (2003) · Current Genomics · doi:10.2174/1389202033490222 · Cited by 5